ArticleScientific reports2025
Predictive model on employee stock ownership impacting corporate performance.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enterprises in the context of smart manufacturing face great challenges in terms of human capital strategies as well as incentive mechanisms. Employee Stock Ownership Plans (ESOPs) is one of the key incentive mechanisms with long-term oriented function, but due to the lack of relevant explanations in the context of smart manufacturing, the mechanism of the dynamic impact of ESOPs on corporate performance has not yet been elucidated. In this study, with the idea of combining AI and accounting, we constructed a prediction model of the impact of ESOPs on enterprise performance that integrates language modeling and social sentiment mass data analysis, and introduced the prediction model to analyze the long-term, dynamic and nonlinear impact of ESOPs on enterprises; finally, we constructed an explainable AI (XAI) based on the LSTM model, and used the SHAP value method to explain the impact of ESOPs on enterprise performance. Finally, the Explainable AI (XAI) is built based on the LSTM model, and the SHAP value method is used to downsize the performance of the complex black box model LSTM, present the model "black box", and analyze the common roles played by the elements of ESOPs, the maturity level of smart manufacturing, and the social sentiment on ESOPs in the long term and nonlinear process. Aiming at the above research problems and shortcomings, the main contributions of this paper include: analyzing the dynamic evolution path of ESOP effectiveness from the perspective of intelligent transformation of manufacturing enterprises; predicting the ESOP effectiveness of enterprises through multi-source heterogeneous data (financial data, social sentiment data, operation data) and advanced AI models (LSTM, LLM), and proposing new prediction tools and prediction theories; using XAI technology to realize ESOP effectiveness; and using XAI technology to realize ESOP effectiveness in the long term and non-linear process. Theory; the use of XAI technology to achieve ESOP incentive effect attribution analysis, for management accounting decision support to provide a new dimension of interpretation, which can be used as a research on ESOP dynamic incentive evaluation, integration of non-financial information, predictive analysis of new perspectives for the field of accounting to develop a new research direction, and for the transformation of intelligent manufacturing design and optimization of ESOP to provide empirical data basis and decision support. The study also provides empirical data basis and decision support for the design and optimization of ESOPs during the transformation of smart manufacturing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.